Research News
View articles by month and year
-
Most Women Share Genetic Test Results with Kids Even Though Value Isn’t Clear
Research has found that women who had abnormal breast cancer gene testing usually shared the test results with their children younger than 25, even though it's not clear that sharing the results with kids this young has value.
-
Breast Cancer Radiation Therapy Linked to Narrowing of Coronary Arteries
A large study found women who'd received radiation therapy to treat early-stage breast cancer were more likely to have narrowing or blockage of the coronary arteries compared to women who hadn't received radiation therapy for breast cancer.
-
Many Women Treated with Brachytherapy Aren’t Good Candidates
A large study has found that many women treated with brachytherapy were not good candidates for that form of radiation therapy based on the characteristics of the breast cancer with which they were diagnosed.
-
When Breast Cancer Doctors Collaborate, Women More Satisfied
A study found that women whose doctors actively collaborated throughout the course of breast cancer treatment were more satisfied with their treatment than women whose doctors didn't collaborate.
-
Oral Bisphosphonates Don’t Seem to Reduce Recurrence Risk
Two studies found that two oral bisphosphonates didn't reduce recurrence risk for women diagnosed with early-stage breast cancer.
-
New Doxorubicin Formula May Be Safer for Heart Than Traditional Formulas
A small study suggests that a new formulation of the chemotherapy medicine doxorubicin may be safer for the heart than traditional formulations.
-
Afinitor Before Surgery Doesn’t Help Treat HER2-Negative Breast Cancer
Research has found that adding Afinitor to paclitaxel didn't improve the response to neoadjuvant treatment with paclitaxel in women diagnosed with advanced-stage, HER2-negative breast cancer.
-
Zometa Can Help Reduce Recurrence Risk of Hormone-Receptor-Positive Disease
Results from three studies all suggest that Zometa can help reduce the risk of cancer recurrence when it's started right after surgery to treat hormone-receptor-positive early-stage breast cancer in postmenopausal and older premenopausal women.
-
Preventively Removing Ovaries May Reduce Bone Density
Research suggests that premenopausal women who have preventive oophorectomy to reduce breast cancer risk may be more likely to have low bone mineral density and arthritis.
-
Removing Breast Tumor May Improve Survival When Metastatic Disease is First Diagnosis
A small study has found that women diagnosed with metastatic breast cancer (with no previous history of early-stage breast cancer) who had surgery to remove the primary tumor in the breast lived longer after diagnosis than women who didn't have the primary tumor removed.
